Showing results (301-310 of 313) with videos related to
Sort By:
Pageof 32
NPJ Precision Oncology|June 7, 2018
Clinical and radiographic response following targeting of BCAN-NTRK1 fusion in glioneuronal tumorChristopher Alvarez-Breckenridge, Julie J Miller, Naema Nayyar, et al.Science (New York, N.Y.)|May 21, 2005
Patient-specific embryonic stem cells derived from human SCNT blastocystsWoo Suk Hwang, Sung Il Roh, Byeong Chun Lee, et al.Acta Neuropathologica Communications|January 16, 2015
Sporadic hemangioblastomas are characterized by cryptic VHL inactivationGanesh M Shankar, Amaro Taylor-Weiner, Nina Lelic, et al.Science Translational Medicine|July 29, 2021
PARIS farnesylation prevents neurodegeneration in models of Parkinson's diseaseAreum Jo, Yunjong Lee, Tae-In Kam, et al.Current Biology : CB|January 14, 2020
Aberrant Tonic Inhibition of Dopaminergic Neuronal Activity Causes Motor Symptoms in Animal Models of Parkinson's DiseaseJun Young Heo, Min-Ho Nam, Hyung Ho Yoon, et al.Nature Genetics|March 24, 2020
Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinomaDavid J H Shih, Naema Nayyar, Ivanna Bihun, et al.Nature Genetics|May 9, 2025
Deciphering the longitudinal trajectories of glioblastoma ecosystems by integrative single-cell genomicsAvishay Spitzer, Kevin C Johnson, Masashi Nomura, et al.Nature Genetics|May 9, 2025
The multilayered transcriptional architecture of glioblastoma ecosystemsMasashi Nomura, Avishay Spitzer, Kevin C Johnson, et al.Cancer Discovery|September 28, 2015
Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic TargetsPriscilla K Brastianos, Scott L Carter, Sandro Santagata, et al.Cancer Research|December 20, 2023
The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment RegimenTathiane M Malta, Thais S Sabedot, Natalia S Morosini, et al.Pageof 32